Sign up to save your podcasts
Or
Share Management of HER2-Altered Non-Small Cell Lung Cancer
Share to email
Share to Facebook
Share to X
Share to email
Share to Facebook
Share to X
Or
Management of HER2-Altered Non-Small Cell Lung Cancer
Dr Bob Li from Memorial Sloan Kettering Cancer Center in New York City discusses the current and future roles of targeted therapy for HER2-altered non-small cell lung cancer.
CME information and select publications here.
View all episodes
By Research To Practice
5
66 ratings
Dr Bob Li from Memorial Sloan Kettering Cancer Center in New York City discusses the current and future roles of targeted therapy for HER2-altered non-small cell lung cancer.
CME information and select publications here.
More shows like Oncology Today with Dr Neil Love
View all
Breast Cancer Update
66 Listeners
Lung Cancer Update
30 Listeners
Hematologic Oncology Update
75 Listeners
Prostate Cancer Update
14 Listeners
Gastrointestinal Cancer Update
17 Listeners
Gastrointestinal Cancer Update
4 Listeners
Oncology Today with Dr Neil Love
2 Listeners
Gynecologic Oncology Update
12 Listeners
Dermatologic Oncology Update
0 Listeners
Research To Practice | Oncology Videos
122 Listeners